Wanfu biological new coronavirus antibody rapid detection reagent quickly approved for market

The novel coronavirus (2019-nCoV) antibody kit (colloidal gold) was developed by the Guangzhou Wanfu biotechnology Limited by Share Ltd in February 23rd It has obtained the registration certificate through the State Food and Drug Administration's emergency examination and approval, and has become the first batch of new crown virus antibody rapid detection reagent that is officially approved The novel coronavirus (2019-nCoV) novel coronavirus assay kit (colloidal gold method) was used to detect the new coronavirus antibody (IgM/IgG) in human serum, plasma and whole blood samples in vitro, 15 The results of the novel coronavirus pneumonia test were quick and convenient for the patients with suspected pneumonia, suspected asymptomatic patients, close contacts and negative nucleic acid test The product can be widely used in hospitals at all levels, fever clinics, CDC, communities, clinics, counties and villages and other medical and health institutions for pre inspection and triage, enterprises and institutions, schools, airports, high-speed rail stations and other public transport hubs, as well as customs inspection and Quarantine of suspected patients Adorable adorable